Evox Therapeutics
Pre-clinicalWe are committed to expanding the reach of genetic medicine into the brain and transforming the treatment landscape for severe neurodegenerative diseases. Evox’s exosome-based therapies are designed to deliver safer, more effective and commercially scalable treatments, drawing on a proprietary gene editor delivered using a vector technology with strong safety track record and excellent brain access.
About
We are committed to expanding the reach of genetic medicine into the brain and transforming the treatment landscape for severe neurodegenerative diseases. Evox’s exosome-based therapies are designed to deliver safer, more effective and commercially scalable treatments, drawing on a proprietary gene editor delivered using a vector technology with strong safety track record and excellent brain access.
Funding History
3Total raised: $209.8M
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile